Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGAV | P06756 | 19/20 | 0.63 |
| ▸ | ITGB3 | P05106 | 10/20 | 0.63 |
| ▸ | ITGB6 | P18564 | 9/20 | 0.45 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.43 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.42 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20156096 | 0.87 | ITGAV (0.67) | ITGAVITGB3ITGB6ITGB1ITGA5 | |
| SCHEMBL20156298 | 0.80 | ITGAV (0.57) | ITGAVITGB3ITGB6ITGA2B | |
| SCHEMBL20141428 | 0.79 | ITGAV (0.74) | ITGAVITGB3ITGB6ITGB1ITGA4 | |
| SCHEMBL23912918 | 0.78 | ITGB3 (0.56) | ITGAVITGB3ITGB6ITGA2B | |
| SCHEMBL6421342 | 0.78 | ITGAV (1.00) | ITGAVITGB3ITGB6 | |
| SCHEMBL6421344 | 0.78 | ITGAV (1.00) | ITGAVITGB3ITGB6 | |
| SCHEMBL20156337 | 0.77 | ITGB3 (0.48) | ITGAVITGB3ITGB6ITGA2B | |
| SCHEMBL21272501 | 0.76 | ITGAV (0.64) | ITGAVITGB3ITGB6ITGA2B | |
| SCHEMBL20139095 | 0.76 | ITGAV (0.64) | ITGAVITGB3ITGB6ITGA2B | |
| SCHEMBL20156098 | 0.76 | CXCR4 (0.47) | ITGAVITGB3ITGB6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3538527-B1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2021-10-13 | — | — | EP | disclosed |
| WO-2018089358-A1 | AZOLE AMIDES AND AMINES AS ALPHA V INTEGRIN INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2018-05-17 | — | — | WO | disclosed |